Hisashi Saji

11PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedSolid tumoursPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 19, 2026
Adenoid cystic carcinoma of the thymus: a case report and literature review.

|Jun 24, 2026
Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

|Jun 22, 2025
Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non-small cell lung cancer in 80 or more aged elderly patients: a randomized phase III study (JCOG2109, AWESOME).

Takahiro Mimae, Masashi Wakabayashi, Yusuke Sano

|Mar 14, 2025
Neoadjuvant dual immuno-combination therapy with anti-LAG3 and anti-PD-1 antibodies is feasible and safe for resectable non-small cell lung cancer.

Naoki Furuya, Takahiro Homma, Hisashi Saji

|Nov 23, 2021
Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.

Tomoyuki Miyazawa, Kei Morikawa, Kanji Otsubo

|Oct 16, 2021
Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas.

Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura

Pageof 2

Frequent Collaborators

4 joint publications

Naoki Furuya

2 joint publications

Tomoyuki Miyazawa

2 joint publications

Kanji Otsubo

2 joint publications

Masamichi Mineshita